Castleview Partners’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Castleview Partners’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,694	Closed	-$11.5K	–	241
2026 Q1	$11.5K	Buy	+15,694	New	+$71.4K	0.01%	199

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Castleview Partners's RVPH Position: Q2 2026 in Review

Castleview Partners sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 15,694 shares — an estimated $11.5K sold.

Castleview Partners first reported a position in RVPH in Q1 2026 and held it in 1 quarter. The position peaked at $11.5K in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Castleview Partners reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Castleview Partners sold 15,694 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $11.5K.
Castleview Partners first reported a position in REVIVA PHARMA HLDGS INC in Q1 2026 and held it in 1 quarter.
Castleview Partners's REVIVA PHARMA HLDGS INC position peaked at $11.5K in Q1 2026.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.